ReviewCurrent drug targets2019

Recognition of Plasminogen Activator Inhibitor Type 1 as the Primary Regulator of Fibrinolysis.

Tetsumei Urano et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.